BHC.TO · Bausch Health Companies Inc.
Canada · RS rating 74 · As of 2026-10-14
| Price | 8.40 CAD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 77 / 90 / 38 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 38 / 61 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | +117.8% |
| Sales growth Q/Q | +13.0% |
| Distance from 52-week high | +23.3% |
| Market cap (USD) | $2.3B |